| Name | Title | Contact Details |
|---|
ProHEALTH is a dynamic and growing healthcare organization, offering a wide range of employment opportunities. As we continue to grow we continually seek qualified, professional, dedicated individuals to join our team. As the largest private
Welcome. Autonomic Technologies, Inc. (ATI) is a medical device company focused on the development and commercialization of innovative therapies for the treatment of severe headache. The company`s initial product, the ATI Neurostimulation System, is approved in Europe for the treatment of cluster headache. The ATI Neurostimulation System was voted #2 among the Cleveland Clinic’s top 10 medical innovations for 2013, and Autonomic Technologies was named one of FierceMedicalDevices’ Fierce 15 most promising privately held medical device and diagnostics companies in the world.
At Medcillary, we provide the latest ancillary products and services that benefit patients and healthcare providers to meet and exceed their unique needs. We are passionate about developing innovative, ground-breaking tests, products and tools to enhance patient care, provide value to our clients, and transform information into knowledge and insights. Our goal is to advance the development and delivery of healthcare and consumer products by providing the highest quality testing possible. Mission: Medcillary was founded with two key principles in place: compliance and clinical relevance with a focus on offering superior and innovative healthcare products aligned to meet the needs of the physicians in our communities, while leading the way for business development and operational excellence through honesty and integrity with our strategic partners. Our vision is to be the most successful and respected medical ancillary solution company in the world. Our core values are: - Commitment - Integrity - Transparency - Pursuit of Excellence - Customer Focus - Respect
Integra group is a Cincinnati, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Since 2007, Genalyte has been guided by the vision of taking a single drop of blood, performing panels of tests and returning accurate and reproducible results within a few minutes. We launched our first instrument in 2012 in the pharmaceutical industry and academia for a range of healthcare applications including autoimmune disease monitoring, screening of cancer biomarkers, testing for infectious agents and detecting anti-drug antibodies. By reducing tests to a microscopic size in a highly multiplex environment on the surface of silicon chips we are able to generate more information from a smaller sample in less time than conventional techniques.